News & Perspective

Jan 25, 2019

Jan 25, 2019

ASP Scan (Weekly) for Jan 25, 2019

Bon Appetit's antibiotics update
Antibiotic-resistant Brucella
New STI test cleared
KFC fulfills antibiotics pledge
Benefit of C diff prevention
Prescribing drop in England
Candida auris increase
Antibiotics for respiratory infections
UTI treatment in older adults
Super donors for fecal transplant
Resistant cholera in Ghana

Nov 30, 2018

Nov 30, 2018

ASP Scan (Weekly) for Nov 30, 2018

Superbugs in Canadian ICUs
Probiotics and ESBL colonization
Antibiotics after rhinoplasty
Rapid flu diagnostic tests
CDC funding for AMR initiatives
VRE, MRSA co-colonization in nursing homes
UV disinfection for C diff
Fluoroquinolones and aortic rupture risk
Resistance action plan
Deaths from MDROs
Stewardship in a Japanese hospital
Stewardship study quality

Feb 03, 2009

Feb 03, 2009

Experts weigh new H5N1 vaccine strategies

(CIDRAP News) – At an Infectious Diseases Society of America (IDSA) symposium in Washington, DC, today on seasonal and pandemic influenza, a group of experts fielded questions from reporters on some of the new trends and emerging issues, including prepandemic strategies for H5N1 avian influenza vaccines, now that some countries are stockpiling them.

Jan 23, 2008

Jan 23, 2008

GAO cites barriers to antiviral, vaccine roles in pandemic

(CIDRAP News) – Antiviral medications and vaccines are two tools that many government and health officials hope will stall the spread of an influenza pandemic, but each strategy has daunting challenges, according to a new report from Congress's Government Accountability Office (GAO).

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Unorthodox Philanthropy logo and text 'Leading Underwriter' 3M logo Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»